Stock Track | PROCEPT BioRobotics Soars 5.24% After-Hours on Better-Than-Expected Q4 2024 Results

Stock Track

Feb 26, 2025

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares surged 5.24% in the after-hours trading session on Tuesday, following the company's fourth quarter 2024 earnings report. The medical device company reported strong revenue growth and a narrower-than-expected loss for the quarter.

According to the earnings report, PROCEPT BioRobotics posted revenue of $68.24 million for the fourth quarter, a 56.6% increase compared to the same period last year. This figure beat analysts' consensus estimate of $66.78 million. The company's adjusted net loss per share of $0.35 also came in slightly better than the expected loss of $0.33 per share.

The solid financial performance and better-than-anticipated results suggest that PROCEPT BioRobotics' products and services are gaining traction in the market. Investors reacted positively to the news, driving the stock higher in the after-hours session as they anticipate continued growth and profitability for the company in the future.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1197497796"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1197497796\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1197497796?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-26 06:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197497796","market":"hk","top_or_hot":-1,"title":"Stock Track | PROCEPT BioRobotics Soars 5.24% After-Hours on Better-Than-Expected Q4 2024 Results","media":"Stock Track","content":"<p>PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares surged 5.24% in the after-hours trading session on Tuesday, following the company's fourth quarter 2024 earnings report. The medical device company reported strong revenue growth and a narrower-than-expected loss for the quarter.</p>\n\n<p>According to the earnings report, PROCEPT BioRobotics posted revenue of $68.24 million for the fourth quarter, a 56.6% increase compared to the same period last year. This figure beat analysts' consensus estimate of $66.78 million. The company's adjusted net loss per share of $0.35 also came in slightly better than the expected loss of $0.33 per share.</p>\n\n<p>The solid financial performance and better-than-anticipated results suggest that PROCEPT BioRobotics' products and services are gaining traction in the market. Investors reacted positively to the news, driving the stock higher in the after-hours session as they anticipate continued growth and profitability for the company in the future.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PROCEPT BioRobotics Soars 5.24% After-Hours on Better-Than-Expected Q4 2024 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PROCEPT BioRobotics Soars 5.24% After-Hours on Better-Than-Expected Q4 2024 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-26 06:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares surged 5.24% in the after-hours trading session on Tuesday, following the company's fourth quarter 2024 earnings report. The medical device company reported strong revenue growth and a narrower-than-expected loss for the quarter.</p>\n\n<p>According to the earnings report, PROCEPT BioRobotics posted revenue of $68.24 million for the fourth quarter, a 56.6% increase compared to the same period last year. This figure beat analysts' consensus estimate of $66.78 million. The company's adjusted net loss per share of $0.35 also came in slightly better than the expected loss of $0.33 per share.</p>\n\n<p>The solid financial performance and better-than-anticipated results suggest that PROCEPT BioRobotics' products and services are gaining traction in the market. Investors reacted positively to the news, driving the stock higher in the after-hours session as they anticipate continued growth and profitability for the company in the future.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRCT","symbol_name":"PROCEPT BioRobotics","start_time":0,"source_url":"","article_id":"1197497796","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197497796","pubTimestamp":1740522391,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PROCEPT BioRobotics Corporation  shares surged 5.24% in the after-hours trading session on Tuesday, following the company's fourth quarter 2024 earnings report. The medical device company reported strong revenue growth and a narrower-than-expected loss for the quarter.According to the earnings report, PROCEPT BioRobotics posted revenue of $68.24 million for the fourth quarter, a 56.6% increase compared to the same period last year. This figure beat analysts' consensus estimate of $66.78 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRCT":"PROCEPT BioRobotics"},"translate_title":"股票跟踪PROCEPT BioRobotics盘后飙升5.24%，2024年第四季度业绩好于预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRCT":1},"content_text":"PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares surged 5.24% in the after-hours trading session on Tuesday, following the company's fourth quarter 2024 earnings report. The medical device company reported strong revenue growth and a narrower-than-expected loss for the quarter.\nAccording to the earnings report, PROCEPT BioRobotics posted revenue of $68.24 million for the fourth quarter, a 56.6% increase compared to the same period last year. This figure beat analysts' consensus estimate of $66.78 million. The company's adjusted net loss per share of $0.35 also came in slightly better than the expected loss of $0.33 per share.\nThe solid financial performance and better-than-anticipated results suggest that PROCEPT BioRobotics' products and services are gaining traction in the market. Investors reacted positively to the news, driving the stock higher in the after-hours session as they anticipate continued growth and profitability for the company in the future.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}